2-NRA Strengthening in India 10.03.2024- Dr Madhur Gupta WHO.pptx1_1 API GMP.pptx1_1 GMP Dr. S. Eswara Reddy.pptx1_2 Impurity Profiling in Drug substances.pptx1_3Presentation on Impurity Profile in Pharmaceutical Products_Draft_25-10-2023.pptx2_1 Stability API DK.ppsx2_1 Stability Studies_Jubilant Generics.pdf2_2 Concepts of OOS, Deviaition, TA, CC 19-10-2023.pdf2_2NON COMPLIANCES OBSERVED IN PARENTERAL & STERILE PREPERATIONS 16102023.ppt2_4 Fermentation 101.pdf2_4 Media_fill_traininig_Pradipta Swain_17_10_2023(1).pptx3_1 Phytopharm_Regulation & GMP Revised.pptx3_1 Phytopharm_Regulation & GMP Revised 1.pptx11.06.24 Ganga.pptx11.4.2023 -WHO GBT Vigilance Function -Indicators and Factsheet- Dr Madhur Gupta.pdf23.2.1 Industry 4.0 in Pharmaceutical Manufacturing & Quality_CDSCO_Mar 2024.pptx23.2.3 Audit Trail Automation.pptx23. Syndicate Activity PPT.pptx25.1.2 Cyber crime-Pharma Sh. OP Meena.ppt25.1.3 Dr. Roy.pptx25.1.4 DELHI SPECIAL COURTS ETC.pptx25. 1. 5 CDSCO Training at New Delhi June 2024 H Mahapatra.pptx25. 2. 1 Bailable and Non Bailable Offences(1).pptx25.2.2 Search & Seizure MSCHAUHAN.pdf25.2.3 Introduction to Cyber MS CHAUHAN.pdf25.3.1. Investigation techniques, launching of prosecution.pptx25.3.2 Drug Insspttor 12 June ACP Prabhat.pptx25.3.3 Method of investigation of NSQ and Spurious drugs_10.06.24 (1).pptx25.3.3 Method of investigation of NSQ and Spurious drugs_10.06.24.pptx25.4.1 .Sushant_NIHFW 13.06.2024.ppt25.4.4 . Punchnama_Dr Naresh Sharma_21.11.2023_NIHFW.pptx25.5.1 Presentation Drugs Inspector trianing - Copy.pptx25. Syndicate Activity PPT.pptxAIDCOC Wiorkshop on Revised Schedule M 8th Oct 23.pptxAIR HANDLING SYSTEM IN PHARMACEUTICAL MANUFACTURING.pdfApplication of AI intelligence in Pharmaceutical Industry-1.pdfArtificial Intelegence.pdfAseptic production Final.pptxAYUSH BIS Final catalogue.pdfbenefit-risk USFDA.pdfc-GMP .pdfCase Studies for Market Surveillance and Control ..pptCDSCO_Industry 4.0_Keerthiveena (1).pptxCIP SIP of Simple and Complex Injections uday kumar pandit session 2 pm.pdfConcepts of OOS, Deviaition, TA, CC 19-10-2023 ASHOK PANWAR.pdfContract-Manufacturing-Arrangements-for-Drugs--Quality-Agreements (1).pdfCRLP(A)_8403_2021.pdfCYTOTOXIC DRUGS PPT 1.pptxD1S07-Keire.pdfData Integrity.pptxDrug regulatory affairs____ (1).pdfExcipient Regulation SRS PPT.pdfExisting Schedule M Vs Revised Schedule-M.pdfFDA Inspection Overview.pptGBT ppt 12.04.2023 final.pptxGroup C PPT Final.pptxHandbook of pharmaceutical liquid products .pdfHandbook of tablet product Formulations.pdfHDP Standards For Pharmaceuticals-BIS.pdfHVAC System Training Presentation.pptxIndianDrugs.pdfIPA Presentation - CCS Case study & Reg Updates.pdfLabelling-Pack-Size-of-Drugs-under-Drugs-Act-1940-Rules-1945.pdfLegal-drafting-of-documents.pdflot release.pptMedical-Devices-Rules-2017.pdfMES Overview_CDSCO_NewDelhi_V1.0.pptxMethod of investigation of NSQ and Spurious drugs_12.06.24.pptxNRA RMA 2023 Dr ARK-modified.pptxNRS (1).pptOOS OOT - Its Importance and SIgnificant - Dr. Milind Joshi (1).pdfPharmaceutical water system and qualification Aditi Shetye (1).pptxPharmaceutical water system and qualification Aditi Shetye.pptxPharma_Stamps_Mar12_2024_without_video.pdfPlanning Inspection .pptxPPT on Market Surveillance and Control- Indicators and Fact Sheet.pptPPT on new criminal Laws-2023(D&C laws ) Aug 2024 final.pdfPresentation - Lyophilization - Ravi Menon 18 Oct 1130AM.pdfProcess validation .pptxPV_Presentattion for FDA.pdfqas20-863-gmp-for-investigational-products.pdfQuality Managemnet and AI DCGI .pdfRanjit Barshikar NIHFW 11 March 24 .pdfRecent Advancements in Analytical Instrumentation Techniques-2.pptxRevised schedule M presentation .pdfRMI.pptxSyndicate Activity Godavari Group.pptxtrs1044-annex-2-gmp-for-sterile-pharmaceutical-products.pdfTSIRD GBT Hyd.pptxV3 AEFI & Role of Partners.pptxValidation of Sterilization process - Rohit Sompura.pptxWater Systems final.pptxWHO GBT LO05 Final.pptxwho guidelines.pdfyamuna ppt - Copy.ppt11. EG and DEG Webinar 13.10.2025.pdfWHO Trainingn tool kit on substandard drugs.pdf